As of October 15, 2026, the FDA’s table of active outbreak investigations lists 50 people sick with E. coli O157:H7 in the outbreak it is investigating with the USDA’s Food Safety and Inspection Service, FDA reference #1421 and FSIS 2026-04. That is double the 25 on the table when the file opened on September 23. The product column still reads “Multi-ingredient wrap with chicken (suspect).” The recall column is still blank. Neither agency has named the manufacturer, the brand, the retailer or a single state where someone got sick.
The public now has a name anyway, and it did not come from the government. On October 15, Marler Clark filed the first lawsuit in the outbreak, alleging that a North Carolina woman and a Massachusetts woman were hospitalized after eating Trader Joe’s Tarragon Chicken Salad Wraps bought in Myrtle Beach, South Carolina, and Allston, Massachusetts, and that their own health departments tied them to this outbreak. A federal complaint should not be how a sick person, her doctor or a county health department interviewer learns which food is under investigation.
I have two draft citizen petitions to the FDA, both dated October 8 and both still being edited before I file them. One asks the FDA to establish that the identity of a firm implicated in an outbreak is not confidential. The other asks it to publish retail consignee lists in Class I recalls. When I wrote about this outbreak on October 8, the count was 38 and I used it as the example in both drafts. A week later the count is 50, and the example has only gotten stronger.
What has changed since October 8
Twelve more people have been added to the count. Food Safety News reports that the USDA is now working to determine whether the chicken in the wraps was used in other products, and that the FDA has started traceback, on-site inspection and sampling without saying what is being traced, where the inspection is or what is being tested. The FDA is still not reporting the patients’ ages or where they live. FSIS, which has jurisdiction because the wraps contain chicken, has posted nothing of its own beyond a link back to the FDA’s table. As far as I can find, the CDC has not posted an investigation notice.
So, the agencies are now asking the right question, where else did this ingredient go, and still declining to tell the public the one fact that would let anyone else help answer it.
The disclosure petition: a name should not depend on which agency regulates the wrap
The draft outbreak firm disclosure petition asks the FDA to establish by rule that the name and location of a firm implicated by epidemiologic, traceback, laboratory or whole genome sequencing evidence is not confidential commercial information; to reach the whole supply chain, not just the brand on the label; and to use the authority it already holds under section 705(b) of the Food, Drug, and Cosmetic Act to name implicated firms now, with or without a recall. It also asks that, in joint investigations with FSIS, the FDA publish the FDA-regulated ingredients under investigation and coordinate so that the public record of a single outbreak does not depend on which agency regulates the finished food.
That last request was written for exactly this file. A chicken wrap is chicken, which belongs to FSIS, wrapped around lettuce, dressing and a tortilla, which belong to the FDA. If the problem is the chicken, FSIS’s own long-standing practice when product is no longer available is to issue a public health alert that names the establishment. It did that as recently as May 2026, when it named The Kebab Shop restaurants and the producer of the beef in an E. coli O157:H7 outbreak tied to beef kofta made four months earlier and long gone from commerce. If the problem is an FDA-regulated ingredient, the FDA has named farms, processors and brands after the product was gone at least eight times since 2006. Either way, somebody holds the authority to name the firm. Three weeks in, nobody has used it.
The consignee petition: “proactively removed” is a recall by another name
Since 2008, FSIS has published the names and locations of retail consignees in Class I meat and poultry recalls by rule, 9 CFR 390.10. That is the model my draft consignee petition asks the FDA to adopt. The weakness in both agencies’ systems is that the obligation attaches to the word “recall.” The FDA says these wraps “were proactively removed from the market before the link to the outbreak was confirmed.” Because nobody called it a recall, nothing was classified, no consignee list was published, and the public was never told which stores sold the wraps.
The draft closes that gap. It asks that any removal of a food identified as the suspected vehicle of an outbreak, whether the firm calls it a recall, a market withdrawal, a stock recovery or a proactive removal, be treated as a recall for purposes of classification and the consignee list, and that the list be published whether or not the product is past its shelf life. The USDA’s new question makes the point for me: if the chicken did go into other products, the public will not know where those went either, unless someone uses the word.
Why this matters when the wraps are gone
Fifty is the number of people whose illnesses have been confirmed and matched by laboratory testing. Food Safety News notes the CDC’s estimate that for every confirmed patient in an E. coli outbreak, 26 go undetected. People who ate a wrap in late August or September are still working their way through emergency rooms, labs and state health departments. A store list is not only about pulling food off a shelf. It tells a patient, a physician and a health department interviewer whether the store where that patient shopped received the suspect food. That is diagnosis and case finding, and neither expires with a shelf-life date.
What should happen now
The FDA and FSIS should name the product, the maker and the retailer, and publish the states, the hospitalizations and the HUS count. FSIS should issue a public health alert on its own 2026-04 investigation and say whether the chicken went into other products and where. And once these petitions are filed, the FDA should grant them, so that the next outbreak does not depend on a lawsuit to tell the public what the government already knows.
The drafts are still open for comment
Neither petition has been filed. I have been asking for help with them for weeks: in Twenty Years After Spinach, where I asked the produce industry to join them; in my open letter to Bruce Taylor, where I asked Taylor Farms and the leafy greens industry to read, improve and support both drafts before I file; and in Put Me Out of the Leafy Green Business, Please, where I asked IFPA, Western Growers, the California and Arizona LGMAs, FMI and NGA to sign them. The chicken wrap outbreak is a reminder that these petitions are not only about lettuce. They reach every food the FDA regulates and every joint file it shares with FSIS.
There is still time to comment. If you are a grower, processor, retailer, public health official, physician, consumer or a family that has lived through an outbreak nobody would name, tell me what is wrong with the drafts and what is missing. Send comments to bmarler@marlerclark.com. I would rather hear it from you now than from the FDA later.
If you ate a chicken wrap in August or September and developed diarrhea, especially bloody diarrhea, see a doctor, ask for a stool test for Shiga toxin-producing E. coli, and report the illness to your local health department.